title: Regulation of neurite growth by inorganic pyrophosphatase 1 via JNK dephosphorylation.
abstract: Neural cell differentiation during development is controlled by multiple signaling pathways, in which protein phosphorylation and dephosphorylation play an important role. In this study, we examined the role of pyrophosphatase1 (PPA1) in neuronal differentiation using the loss and gain of function analysis. Neuronal differentiation induced by external factors was studied using a mouse neuroblastoma cell line (N1E115). The neuronal like differentiation in N1E115 cells was determined by morphological analysis based on neurite growth length. In order to analyze the loss of the PPA1 function in N1E115, si-RNA specifically targeting PPA1 was generated. To study the effect of PPA1 overexpression, an adenoviral gene vector containing the PPA1 gene was utilized to infect N1E115 cells. To address the need for pyrophosphatase activity in PPA1, D117A PPA1, which has inactive pyrophosphatase, was overexpressed in N1E115 cells. We used valproic acid (VPA) as a neuronal differentiator to examine the effect of PPA1 in actively differentiated N1E115 cells. Si-PPA1 treatment reduced the PPA1 protein level and led to enhanced neurite growth in N1E115 cells. In contrast, PPA1 overexpression suppressed neurite growth in N1E115 cells treated with VPA, whereas this effect was abolished in D117A PPA1. PPA1 knockdown enhanced the JNK phosphorylation level, and PPA1 overexpression suppressed it in N1E115 cells. It seems that recombinant PPA1 can dephosphorylate JNK while no alteration of JNK phosphorylation level was seen after treatment with recombinant PPA1 D117A. Enhanced neurite growth by PPA1 knockdown was also observed in rat cortical neurons. Thus, PPA1 may play a role in neuronal differentiation via JNK dephosphorylation.
authors.affiliation: Department of Pharmacotherapeutics, School of Pharmacy, Iwate Medical University, Iwate, Japan.
authors.forename: Yu
authors.initials: Y
authors.lastname: Tezuka
authors.forename: Mizuki
authors.initials: M
authors.lastname: Okada
authors.forename: Yuka
authors.initials: Y
authors.lastname: Tada
authors.forename: Junji
authors.initials: J
authors.lastname: Yamauchi
authors.forename: Hideo
authors.initials: H
authors.lastname: Nishigori
authors.forename: Atsushi
authors.initials: A
authors.lastname: Sanbe
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D019943:Amino Acid Substitution; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D045744:Cell Line, Tumor; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects; D005822:Genetic Vectors; D043564:Inorganic Pyrophosphatase / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D048670:MAP Kinase Kinase 4 / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D010766:Phosphorylation; D061251:Primary Cell Culture; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism; D051381:Rats; D015398:Signal Transduction / Q000187:drug effects; D014635:Valproic Acid / Q000494:pharmacology
chemical_list: D034741:RNA, Small Interfering; D014635:Valproic Acid; D048670:MAP Kinase Kinase 4; D043564:Inorganic Pyrophosphatase